No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Comment
MeSH terms
-
Animals
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Antineoplastic Agents, Phytogenic / therapeutic use*
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Camptothecin / pharmacology
-
Camptothecin / therapeutic use*
-
Child
-
Chromosome Breakage
-
Clinical Trials as Topic
-
DNA Damage*
-
DNA Replication / drug effects
-
DNA Topoisomerases, Type I / metabolism
-
DNA, Neoplasm / drug effects*
-
Drug Administration Schedule
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use*
-
Humans
-
Irinotecan
-
Mice
-
Multicenter Studies as Topic
-
Neoplasm Proteins / antagonists & inhibitors*
-
Neuroblastoma / drug therapy
-
Neuroblastoma / enzymology
-
Neuroblastoma / genetics
-
Rhabdomyosarcoma / drug therapy
-
Rhabdomyosarcoma / enzymology
-
Rhabdomyosarcoma / genetics
-
Topoisomerase I Inhibitors*
-
Topotecan / pharmacology
-
Topotecan / therapeutic use
-
Xenograft Model Antitumor Assays
Substances
-
Antineoplastic Agents, Phytogenic
-
DNA, Neoplasm
-
Enzyme Inhibitors
-
Neoplasm Proteins
-
Topoisomerase I Inhibitors
-
Irinotecan
-
Topotecan
-
DNA Topoisomerases, Type I
-
Camptothecin